0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Basal Cell Carcinoma (Basal Cell Epithelioma) - Epidemiology Forecast to 2028
Published Date: February 2019
|
Report Code: DELV-Epid-22
Home | Market Reports | Health | Health Conditions | Skin Conditions
Basal Cell Carcinoma Epidemiology Forecast to 2028

Global Basal Cell Carcinoma (Basal Cell Epithelioma) - Epidemiology Forecast to 2028

Code: DELV-Epid-22
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Basal Cell Carcinoma (Basal Cell Epithelioma) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Basal Cell Carcinoma (Basal Cell Epithelioma) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Basal Cell Carcinoma (Basal Cell Epithelioma) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma) outlook. It also includes the explanation of changing trends of epidemiology outlining the Basal Cell Carcinoma (Basal Cell Epithelioma) scenario.

Basal Cell Carcinoma (Basal Cell Epithelioma) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Basal Cell Carcinoma (Basal Cell Epithelioma) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Basal Cell Carcinoma (Basal Cell Epithelioma) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Basal Cell Carcinoma (Basal Cell Epithelioma) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Basal Cell Carcinoma (Basal Cell Epithelioma)

Key assessments
• Patient Segmentation in Basal Cell Carcinoma (Basal Cell Epithelioma)
• Basal Cell Carcinoma (Basal Cell Epithelioma) Risk & Burden
• Factors driving growth in a specific Basal Cell Carcinoma (Basal Cell Epithelioma) patient population


1. Report Introduction
2. Basal Cell Carcinoma (Basal Cell Epithelioma) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Basal Cell Carcinoma (Basal Cell Epithelioma) in 2016
2.2. Patient Share Distribution of Basal Cell Carcinoma (Basal Cell Epithelioma) in 2028
3. Disease Background and Overview: Basal Cell Carcinoma (Basal Cell Epithelioma)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM – By Countries
5. Epidemiology of Basal Cell Carcinoma (Basal Cell Epithelioma) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.1.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.1.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.1.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.4.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.4.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.4.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.5.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.5.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.5.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.6.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.6.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.6.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.7.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.7.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.7.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.8.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.8.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.8.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
5.9.3. Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.9.4. Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) *
5.9.5. Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma)
6. Unmet Needs of the Basal Cell Carcinoma (Basal Cell Epithelioma)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight

List of Tables

Table 1: Total Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM
Table 2: Total Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028) *
Table 14: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Basal Cell Carcinoma (Basal Cell Epithelioma) in Japan (2016-2028)

 

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India